Logo image of QUOT

Quotient Technology Inc (QUOT) Stock Fundamental Analysis

USA - NYSE:QUOT - US7491191034 - Common Stock

3.99 USD
0 (0%)
Last: 9/1/2023, 8:04:00 PM
3.99 USD
0 (0%)
After Hours: 9/1/2023, 8:04:00 PM
Fundamental Rating

2

QUOT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 95 industry peers in the Media industry. QUOT has a bad profitability rating. Also its financial health evaluation is rather negative. QUOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

QUOT had negative earnings in the past year.
QUOT had a positive operating cash flow in the past year.
QUOT had negative earnings in each of the past 5 years.
QUOT had a positive operating cash flow in 4 of the past 5 years.
QUOT Yearly Net Income VS EBIT VS OCF VS FCFQUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M -40M -60M

1.2 Ratios

QUOT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QUOT Yearly ROA, ROE, ROICQUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

With a decent Gross Margin value of 49.75%, QUOT is doing good in the industry, outperforming 64.95% of the companies in the same industry.
QUOT's Gross Margin has declined in the last couple of years.
QUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.43%
GM growth 5Y-3.81%
QUOT Yearly Profit, Operating, Gross MarginsQUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

QUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QUOT has more shares outstanding
Compared to 1 year ago, QUOT has an improved debt to assets ratio.
QUOT Yearly Shares OutstandingQUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
QUOT Yearly Total Debt VS Total AssetsQUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.44, we must say that QUOT is in the distress zone and has some risk of bankruptcy.
QUOT has a Altman-Z score of -0.44. This is in the lower half of the industry: QUOT underperforms 78.35% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that QUOT is not too dependend on debt financing.
QUOT has a Debt to Equity ratio of 0.30. This is in the better half of the industry: QUOT outperforms 69.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -0.44
ROIC/WACCN/A
WACC8.13%
QUOT Yearly LT Debt VS Equity VS FCFQUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

QUOT has a Current Ratio of 1.37. This is a normal value and indicates that QUOT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, QUOT is doing worse than 60.82% of the companies in the same industry.
QUOT has a Quick Ratio of 1.37. This is a normal value and indicates that QUOT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, QUOT is in line with its industry, outperforming 41.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
QUOT Yearly Current Assets VS Current LiabilitesQUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.44% over the past year.
Looking at the last year, QUOT shows a very negative growth in Revenue. The Revenue has decreased by -38.13% in the last year.
QUOT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.16% yearly.
EPS 1Y (TTM)47.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.44%
Revenue 1Y (TTM)-38.13%
Revenue growth 3Y-12.85%
Revenue growth 5Y-2.16%
Sales Q2Q%-5.12%

3.2 Future

Based on estimates for the next years, QUOT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.32% on average per year.
QUOT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.18% yearly.
EPS Next Y75%
EPS Next 2Y42.74%
EPS Next 3Y29.32%
EPS Next 5YN/A
Revenue Next Year-6.16%
Revenue Next 2Y0.48%
Revenue Next 3Y2.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QUOT Yearly Revenue VS EstimatesQUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
QUOT Yearly EPS VS EstimatesQUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

QUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 130.39, the valuation of QUOT can be described as expensive.
QUOT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. QUOT is more expensive than 69.07% of the companies in the same industry.
QUOT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 130.39
QUOT Price Earnings VS Forward Price EarningsQUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QUOT Per share dataQUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as QUOT's earnings are expected to grow with 29.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.74%
EPS Next 3Y29.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QUOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Quotient Technology Inc

NYSE:QUOT (9/1/2023, 8:04:00 PM)

After market: 3.99 0 (0%)

3.99

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-08 2023-08-08/amc
Earnings (Next)11-06 2023-11-06/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners7.64%
Ins Owner Change0%
Market Cap397.92M
Analysts45.71
Price Target4.08 (2.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-133.79%
Min EPS beat(2)-171.49%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-179.71%
Min EPS beat(4)-271.57%
Max EPS beat(4)-96.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.04%
Min Revenue beat(2)-6.87%
Max Revenue beat(2)-3.21%
Revenue beat(4)0
Avg Revenue beat(4)-8.73%
Min Revenue beat(4)-17.12%
Max Revenue beat(4)-3.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-344.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 130.39
P/S 1.5
P/FCF N/A
P/OCF 73.77
P/B 2.56
P/tB 16.14
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)0.03
Fwd EY0.77%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.05
OCFY1.36%
SpS2.67
BVpS1.56
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.75%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.43%
GM growth 5Y-3.81%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.69%
Cap/Sales 7.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z -0.44
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)63.54%
Cap/Depr(5y)74.54%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.44%
EPS Next Y75%
EPS Next 2Y42.74%
EPS Next 3Y29.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.13%
Revenue growth 3Y-12.85%
Revenue growth 5Y-2.16%
Sales Q2Q%-5.12%
Revenue Next Year-6.16%
Revenue Next 2Y0.48%
Revenue Next 3Y2.18%
Revenue Next 5YN/A
EBIT growth 1Y30.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.87%
EBIT Next 3Y58.55%
EBIT Next 5YN/A
FCF growth 1Y-168.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85%
OCF growth 3YN/A
OCF growth 5YN/A